HBI Deals+Insights / M&A/IPOs
On October 11, Reuters reported that Sanofi, the French drugmaker, is negotiating a €16.4 billion sale of a 50% stake in its consumer health business, Opella, to US private equity firm Clayton Dubilier & Rice (CD&R). This move is part of Sanofi's strategy to separate its consumer healthcare segment to fund new drug development.